Loading ...

BCG to Prevent COVID-19

(

BOLSTER

)

ITN Protocol #:

ITN094AI

Branded Name:

BOLSTER

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Withdrawn

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

BCG-JAPAN VACCINATION TO PREVENT COVID-19 IN HEALTHCARE WORKERS

Clinical Operations Manager

NIAID Project Manager

Study Personnel:

Protocol Chair

Audrey Plough aplough@immunetolerance.org

Work:

415-278-0709

Protocol Chair

Sean McCarthy sean.mccarthy@nih.gov

Work:

Admin Links

Shortcuts

ITN Documents

Links